Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

Efficacy of stem cell therapy for achilles tendon rupture: a systematic review and meta-analysis based on animal studies

Li B., Wang X., Ma J., Hu D., Liu L., Lu J.

Meta-analysis on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Front Bioeng Biotechnol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42305811
PMCID
PMC13265556
DOI
10.3389/fbioe.2026.1753018

Abstract (original English)

Background Although stem cell-based therapies show promise for promoting Achilles tendon regeneration, the current preclinical evidence is highly heterogeneous, and their overall efficacy and key modifying factors remain unclear. Methods We systematically searched PubMed, Web of Science, Embase, and Scopus for studies based on rat models of Achilles tendon rupture. Two investigators independently performed study selection, data extraction, and risk-of-bias assessment. Meta-analyses were conducted using R software. Results Twenty-seven studies were included. Pooled analyses showed that stem cell transplantation significantly improved ultimate load and histological scores of the Achilles tendon, with effects increasing over time. However, the impact of stem cell therapy on tendon stiffness was limited. For type I collagen, stem cell transplantation alone did not significantly enhance its expression, whereas combining stem cells with biomaterial scaffolds led to a marked increase. Subgroup analyses revealed a complex relationship between stem cell dose and treatment efficacy: for ultimate load, a moderate dose was effective at 2 weeks, while a high dose was more effective at 4 weeks; for histological scores, both low and moderate doses were effective at 2 weeks, whereas only moderate-to-high doses were effective at 4 weeks, indicating a nonlinear and time-dependent dose-response p

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research